ChromaVision CEO Andrews
This article was originally published in The Gray Sheet
Ronald Andrews, Jr., formerly senior VP-global marketing and commercial business development at Roche Molecular Diagnostics, is appointed president & CEO of the San Juan Capistrano, Calif. firm. Chairman Michael Cola has been interim CEO since the role was vacated in February...
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.